Farther Finance Advisors
CTNM icon

Farther Finance Advisors’s Contineum Therapeutics CTNM Stock Holding History

Farther Finance Advisors’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27 Buy
+2
New +$30 ﹤0.01% 6058

Other funds holding CTNM

Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's CTNM Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 2 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #6058 among its holdings.

4 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Farther Finance Advisors held 2 shares of Contineum Therapeutics worth $27 as of Q3 2026.
  • Contineum Therapeutics was a new Farther Finance Advisors position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6058 holding.
  • 4 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.